Ovran - Drug info, indications, side effects, dosage, FAQ

Learn all about Ovran

Usage of Ovran

Indications: Oral contraception
Contra Indications: 1. CARDIOVASCULAR History of arterial or venous thrombosis, family history of venous thrombosis, other known risk factors for venous thrombosis, clotting disorders, ischaemic heart disease, angina. Transient ischaemia. Valvular heart disease, atrial fibrillation, pulmonary hypertension. Sickle cell anaemia. 2. HEPATIC History of cholestatic jaundice of pregnancy. Disorders of hepatic excretion (Dubin-Johnson/Rotor syndromes). Infectious hepatitis of any type. Abnormal liver function tests. Porphyria, Liver adenoma. 3. OTHER Pemphigoid gestationis, haemolytic uraemic syndrome, chorea, otosclerosis. Hormone dependent carcinoma. Undiagnosed vaginal bleeding. Recent trophoblastic disease. Pregnancy

Drug description Ovran

Drug description: Ovran: white s-c tablets marked WYETH. Ovran 30: white s-c tablets marked WYETH one side
Generic name: Ethinylestradiol [ethinyloestradiol], levonorgestrel
Drug class description: Oestrogens / progestogens

Special precautions Ovran

Hypertension, Raynaud's disease, diabetes, varicose veins, asthma, severe depression, chronic renal disease, multiple sclerosis, renal dialysis, hyperprolactinaemia. Risk of with oral contraception is increased with age, smoking and obesity. Examine blood pressure, pelvic organs and breasts before and regularly during treatment

Adverse and side effects Ovran

Breast enlargement, bloating with fluid retention. Cramps and pains in the legs. Depression. Loss of libido. Headaches, nausea, vaginal discharge and cervical erosion. Weight gain. Breakthrough bleeding. Chloasma. REASONS FOR IMMEDIATE DISCONTINUATION OF TREATMENT: Occurrence of migraine-type headaches for the first time or frequent severe headaches. Acute visual or auditory disturbances. First signs of thrombophlebitis or thromboembolism. Rise in blood pressure. Jaundice. Pregnancy. Discontinue six weeks before major elective surgery and during immobilization. Post-operatively, they should normally be restarted two weeks after the patient is fully mobile. These recommendations need not apply to minor surgical procedures with short duration of anaesthesia and early mobilisation except minor procedures to the legs. When discontinuation is not possible, prophylactic low dose, sub- cutaneous heparin may be considered

Presentation Ovran

  • Ovran Ovran: Ethinylestradiol 50 microgram s, levonorgestrel 250 microgram s. Ovran 30: Ethinylestradiol 30 microgram s, levonorgestrel 250 microgram s

Do you have a question about Ovran?

Ask thousands of Doctoralia experts anonymously and for free

  • Your question will be published anonymously
  • Make it one, clear, medical question
  • Be brief
  • This service doesn´t replace a consultation with a medical professional. If you have a problem or emergency, go to a doctor or an emergency room.
  • Questions about a specific case or second opinion requests will not be allowed.
In order to improve our service we are using our own and third-party cookies. By continuing to use this site, you agree to our cookie policy. More info X